Search results
Results From The WOW.Com Content Network
The maker of vaccines, including the mRNA vaccine for COVID-19, is amid a 90% stock price downturn. In fact, the share price is now only right around the same level as it was before the 2020 pandemic.
Yahoo Finance Live anchor Seana Smith highlights stocks moving in after-hours trading, including Ford, FedEx, and Moderna.
Moderna's (NASDAQ: MRNA) sales are slowing down, and Moderna stock is going down -- a lot.. The coronavirus vaccine maker's shares plunged 21.2% through 10:20 a.m. ET Monday after it updated ...
Without a growing base of revenue, it's hard to craft a compelling investment thesis for Moderna or any other stock. Moderna's trailing-12-month revenue is just over $5 billion, down by 77% from ...
If we assume Moderna only hits the low end of its 2025 revenue forecast, the stock trades at roughly 9 times forward sales. That's well above the 7.2 price-to-sales ratio for the biotech industry.
Moderna stock (MRNA) fell over 9% on Wednesday, forfeiting most of its gains from Tuesday's session during a volatile week for the stock seen after the first reported bird flu death in the US ...
The company's stock was trading slightly up on the news early Monday before falling after market open. Moderna is up almost 20% in the last month after the company received approval from the FDA ...
Why Moderna stock fell. Moderna's bizarre stock price performance during the week ending May 31 had two main factors. First, ... The Today Show.